Rocamora, Merra Luz C.

HRN: 21-19-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2022
AMPICILLIN 1GM (VIAL)
04/24/2022
04/30/2022
IVT
2g
Q6
PROM
Waiting Final Action 
04/25/2022
CEFUROXIME 500MG (TAB)
04/25/2022
05/01/2022
PO
500mg
BID
Postpartum
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: